Table 1.
Age groups | 21–25 | 26–30 | 31–35 | 36–40 | 41–49 | 50–70 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total n | n = 36 | n = 33 | n = 28 | n = 22 | n = 27 | n = 22 | ||||||
Ind w / vac info | 20 | 17 | 17 | 10 | 9 | 9 | ||||||
Status | vac | unvac | vac | unvac | vac | unvac | vac | unvac | vac | unvac | vac | unvac |
Total n per status | 10 | 10 | 5 | 12 | 2 | 15 | 0 | 10 | 0 | 9 | 0 | 9 |
oHPVvac_type | 0 | 6 | 0 | 4 | 1 | 6 | 0 | 2 | 0 | 2 | 0 | 2 |
oHPVnon_vac_type | 7 | 2 | 0 | 6 | 0 | 6 | 0 | 1 | 0 | 3 | 0 | 5 |
pro_oHPV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
non_oHPV | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
HPVneg | 2 | 2 | 5 | 2 | 1 | 3 | 0 | 6 | 0 | 3 | 0 | 2 |
HPV human papillomavirus, Ind w/ vac info number of individuals for whom vaccination status information is available, Total n per status number of individuals per vaccination status, oHPVvac_type oncogenic HPV type included in the vaccine, oHPVnon_vac_type oncogenic HPV type not included in the vaccine, pro_oHPV probably oncogenic HPV type, non_oHPV non-oncogenic HPV type, HPVneg HPV negative.